GRACE SCHONHARDT: Open Payments
NPI 1700187523 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 10 payments from 5 companies in 2025. Trend: 2023 $555 · 2024 $1,492 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $267 |
| SANOFI-AVENTIS U.S. LLC | 1 | $146 |
| Lilly USA, LLC | 2 | $146 |
| Abbott Laboratories | 1 | $130 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
Products named: TZIELD, Wegovy, FREESTYLE LIBRE 3, FANAPT, Ozempic, ZEPBOUND, MOUNJARO.
Industry payments across HI — which companies pay providers there.
